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2ABSTRACT 
PURPOSE:  To determine the effect of reducing MAP kinase phosphatase-1 (MKP-1) 
levels on cell death induced by glucocorticoid (GC) or hydroxyurea (HU) treatment in the 
human pre-B acute lymphoblastic leukemia cell line 697.  METHODS:  Stable MKP-1 
overexpressing transformants of the 697 pre-B ALL cell line were created and tested for 
sensitivity to the GC triamcinolone acetonide (TA) and HU, and compared to a control 
697 cell line containing normal MKP-1 expression levels.  Small interfering RNAs 
(siRNAs) were designed to inhibit MKP-1 expression and evaluated for their effect on 
GC-mediated cell death.  RESULTS:  MKP-1 overexpression caused a phenotype of 
partial resistance to HU-induced apoptosis but not to GC-induced apoptosis.  
Electroporation of siRNAs effectively silenced MKP-1 expression, and increased 
sensitivity to TA by 9.6±1.9%.  CONCLUSIONS:  Because MKP-1 protects certain 
tumor cells from chemotherapy-induced apoptosis, its inhibition is being considered as a 
possible strategy for combination cancer therapy.  However, this study suggests that 
while MKP-1 inhibition may improve the efficacy of DNA damaging agents, it may have 
only limited utility in combination with glucocorticoids. 
 
INTRODUCTION 
 Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, 
with approximately 5000 new cases reported annually (Cortes and Kantarjian 1995).  The 
standard course of therapy includes both classical chemotherapeutics such as vincristine 
as well as glucocorticoids (GC) such as dexamethasone, prednisone, or triamcinolone 
(Cortes and Kantarjian 1995).  Although this regimen leads to a cure rate of >70%, poor 
prognosis often correlates with resistance to GCs (Tissing et al. 2003).  Precursor B cell 
ALL is the most prevalent form of this disease, ~10-20% of which contain a t(1;19) 
3chromosomal translocation (Raimondi et al. 1990).  This translocation creates the E2A-
Pbx chimeric transcription factor, which has oncogenic properties (Kamps et al. 1991) 
and causes aberrant expression of signaling proteins such as Wnt-16 (McWhirter et al. 
1999) and N-Myc (Rutherford et al. 2001).  The pre-B ALL cell line 697, a well-
characterized GC-sensitive, t(1;19) positive cell line isolated from a 12 year old patient, 
is a useful model for studying signal transduction pathways in this disease (Findley et al. 
1982). 
 GCs induce apoptosis in numerous hematopoietic tissues of both lymphoid and 
myeloid lineage in a process that requires the glucocorticoid receptor (GR), a GC-
activated transcription factor of the nuclear receptor superfamily (Planey and Litwack 
2000).  GR activation by GC induces dissociation of GC-GR from a large cytoplasmic 
complex and translocation to the nucleus, where GC-GR affects mRNA levels of target 
genes by interacting directly with promoter DNA or by binding to other transcription 
factors (McEwan et al. 1997).  Apoptosis occurs downstream of these transcriptional 
effects, and involves the biochemical hallmarks of the intrinsic cell death pathway:  
release of cytochrome c from the mitochondria, cleavage of caspase-9 and DNA 
fragmentation (Planey et al. 2002).  In the cell line 697, GC rapidly induces or represses 
>100 genes, including a number of interesting candidates for mediators of this pathway.  
These target genes include BCL2 family members, the FOXO3A transcription factor, a G-
protein coupled receptor GPCR18, and MAP kinase phosphatase-1 (MKP1) (Planey et al. 
2003). 
 MKP-1 protein is a dual-specificity phosphatase that exhibits anti-apoptotic 
effects by negatively regulating the stress-induced mitogen activated protein kinases 
(MAPKs), c-Jun N-terminal kinase (JNK) and p38 (Slack et al. 2001).  Hence, MKP-1 
has emerged as an appealing GR target gene (Clark 2003).  MKP1mRNA and MKP-1 
4protein are both strongly and rapidly repressed by GC-GR in 697 cells before they 
apoptose, which led us to the hypothesis that alleviating negative regulation of pro-
apoptotic MAPKs contributes to this mechanism (Planey et al. 2003).  On the contrary, 
MKP-1 protein is induced by GC in numerous non-hematopoietic tissues including 
mammary epithelial cells, which initiate a survival response after exposure to GC (Wu et 
al. 2004).   Interestingly, it has been shown recently that silencing MKP1 gene expression 
by RNA interference in MCF-7 breast cancer cells inhibits GC-mediated survival after 
paclitaxel treatment (Wu et al. 2004).  Thus, it is possible that differential regulation of 
MKP-1 is a mechanism by which GC can cause opposite biological outcomes (survival 
versus apoptosis) in different tissues.   Finally, given that MKP-1 is overexpressed in a 
variety of human cancers (Bang et al. 1998; Kurt et al. 1998), and that GCs are 
administered routinely to reduce the nausea and acute toxicity caused by 
chemotherapeutics, it is of considerable clinical interest to investigate the role of MKP-1 
in GC-mediated effects. 
 In this study, we determined the effect of modulating MKP-1 expression levels 
on GC-induced apoptosis in the cell line 697.  Based on the hypothesis stated above, 
MKP-1 overexpression would be expected to cause GC resistance, compared with cells 
containing only endogenous levels of MKP-1.  However, strong overexpression of MKP-
1 cDNA in 697 cells did not affect GC sensitivity or caspase-3 activation, even though it 
caused partial resistance to another chemotherapeutic agent, hydroxyurea.  We also 
designed and validated small RNA duplexes (reviewed by Caplen and Mousses, 2003) 
that significantly reduced MKP-1 expression.  Silencing of MKP1 mRNA by RNA 
interference had a modest effect on GC sensitivity.  These data establish that MKP-1 is 
not likely to be a critical mediator of GC signaling in pre-B ALL and underscore the 
importance of investigating the tissue-specific mechanisms of GC signal transduction. 
5MATERIALS AND METHODS 
 
Compounds and reagents: Triamcinolone acetonide (TA) was purchased from Sigma (St. 
Louis, MO) and dissolved in 100% ethanol.  The final concentration of ethanol in all cell 
treatments was kept constant at 0.1 %.  Hydroxyurea (Sigma) was dissolved in phosphate 
buffered saline (PBS).  All siRNAs were purchased from Dharmacon (Lafayette, CO).  
The GL2 firefly luciferase siRNA sequence (Elbashir et al. 2001) was used as the control 
for all siRNA experiments, and this sequence was also used for both the FITC and Cy3 
labeled siRNAs.  All tissue culture and electrophoresis reagents were purchased from 
Invitrogen (Carlsbad, CA) except where otherwise indicated. 
 
Cell culture and cDNA overexpression: 697 pre-B ALL cells were grown in RPMI 1640 
medium containing 10% fetal bovine serum and penicillin/streptomycin mix.  MKP-1 
cDNAs were a generous gift from Dr. Steve Keyes and Dr. Chris Franklin. The 
BamH1/EcoR1 fragment from MKP-1/pSG5 (Groom et al. 1996) was subcloned into a 
pcDNA3.1 expression vector (Invitrogen).  60 µg of this plasmid, as well as the empty 
vector, were transfected by electroporation into 697 cells as described (Planey et al. 
2003).  48 h later, 1 µg/mL G418 was added to the growth medium.  After one week, 
resistant cells were seeded in 96-well plates at limiting dilutions.  Clonal isolates were 
expanded for screening after approximately 4 weeks.  697 cells overexpressing dominant-
negative caspase-9 were as described in (Planey et al. 2003). 
 
6Immunoblots: For all of the MKP-1 immunoblots, 40-50 µg of whole-cell lysate from 
each clone was electrophoresed on Tris-glycine 10% polyacrylamide gels.  Samples were 
transferred to polyvinylidene fluoride membranes, blocked in PBS containing 5% 
powdered milk and 0.5% Tween-20, and immunoblotted with an anti-MKP-1 polyclonal 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:100 in PBS containing 
0.5% Tween-20, or an anti-GAPDH antibody (Research Diagnostics, Flanders, NJ) 
diluted 1:20000.  After washing, detection was performed using an anti-rabbit secondary 
antibody conjugated to horseradish peroxidase (Santa Cruz Biotechnology) and a 
chemiluminescent substrate (SuperSignal, Pierce, Rockford, IL).  
 
Real time RT-PCR: Total RNA was purified from 1 × 107 cells for each cell line using 
RNeasy columns (Qiagen, Valencia, CA).  RT-PCR reactions were performed in 
duplicate using Taqman One Step reagents in an ABI 7900 Sequence Detection System 
(Applied Biosystems, Foster City, CA).  0.1 µg of template RNA was used per reaction.  
Primer/probe sequences and concentrations were the same as in Planey et al. (2003).   
 
Flow cytometry: For cell cycle analysis, cells were treated in 6-well plates, washed with 
PBS, fixed in 70% ethanol, and stained with 50 µg/mL propidium iodide containing 1 
mg/mL RNase A and 1 mg/mL glucose (all from Sigma) for 30 min.  Samples were 
processed on a FACSCalibur instrument (BD Biosciences, San Jose, CA) and data were 
analyzed using FACSComp software. 10,000 cells were collected for each measurement. 
For viability analysis, samples were resuspended in 500 µL of 0.1 M HEPES-NaOH pH 
7.4, 1.4 M NaCl, 25 mM CaCl2 containing 0.5 µg/mL 7-aminoactinomycin-D (BD 
Pharmingen, San Diego, CA).  7-AAD content was measured using a Beckman Coulter 
7XL flow cytometer and data were analyzed using WinMDI software. 50,000 cells were 
counted for each measurement. 
 
Caspase-3 activity: 1 × 105 cells per well were seeded in 96-well plates in triplicate for 
each condition.  After drug treatment, cells were subjected to assay using ApoAlert 
(Clontech, Palo Alto, CA) reagents including the DEVD-AFC substrate, and detected 
fluorimetrically according to the manufacturer’s protocol. 
 
siRNA transfection: Exponentially growing 697 cells were washed twice with PBS and 
resuspended in serum-free RPMI-1640 media containing 25 mM HEPES-NaOH pH 7.4 
(without phenol red or antibiotics) at 107 cells/mL.  200 µL aliquots of cells were added 
to 0.2 cm gap electroporation cuvets (Bio-Rad, Hercules, CA). siRNA (10 µL of a 20 µM 
stock solution for a final concentration of 1 µM) was added and incubated at room 
temperature for 20 min. Cells were then electroporated with a Bio-Rad Gene Pulser using 
voltage and capacitance settings of 220 V and 500 µF, respectively.  Cells were incubated 
for an additional 20 min., and added to 3 mL of the above medium supplemented with 
10% FBS (final siRNA concentration after dilution was 66 nM) and allowed to recover at 
37ºC for the indicated times (excluding aggregated cell debris).   
 
Cell Sorting: Cells were transfected as above except that FITC-siRNA was added to 0.25 
µM in each cuvet.  Three electroporations were pooled together for each condition to 
obtain enough cells to sort efficiently.  After 18 h, cells were collected and resuspended 
in medium containing 5% FBS.  Cells were sorted based on FITC content using a EPICS 
Elite cytometer (Beckman Coulter, Fullerton, CA) into 50% growth medium / 50% FBS 
8and allowed to recover  for 30 min.  Cells were then re-seeded and either harvested for 
immunoblotting or treated with compounds for viability assay after an additional 24 h. 
 
RESULTS 
 
We showed previously that GC-induced apoptosis is associated with rapid down-
regulation of MKP-1 mRNA and protein in the pre-B ALL cell line 697, an event that is 
completely abrogated by the GR antagonist RU486 (Planey et al. 2003).  This repression 
of MKP-1 correlated well with an increase in the activity of its primary substrate, c-Jun 
N-terminal linase (JNK) (Planey et al. 2003). To determine whether interfering with 
MKP-1 repression by GC-GR affects the sensitivity of 697 cells to GC, we created stable 
clones derived from the 697 line that strongly overexpress MKP1 cDNA.  After selecting 
plasmid-transfected clones derived from single cells for approximately 6 weeks, we 
screened 4 clones expressing MKP1 cDNA by immunoblotting, in addition to a clone 
transfected with empty vector as a control (Fig. 1a).  Two of those clones strongly 
overexpressed MKP-1 protein as compared to the empty vector control.  We used the 
highest-expressing cell line (Fig. 1a, lane 5) for all subsequent experiments. To confirm 
overexpression at the mRNA level, we performed real-time RT-PCR (Fig. 1b).  Duplicate 
RT-PCR data showed a reduction of 1.5 PCR cycles in the threshold cycle (Ct) value of 
MKP-1 overexpressing cells when compared to empty vector cells, which corresponds to 
a 3-fold increase in steady state mRNA concentration (21.5).  A probe for 18S rRNA was 
included as a loading control.  The large increase in steady-state protein levels, as 
compared to the moderate increase in steady-state mRNA levels, suggests that the 
exogenous MKP-1 protein is remarkably stable after synthesis. 
9To determine if the sensitivity of the 697 cells to GC was decreased after MKP-1 
overexpression, we treated the MKP-1 and empty vector-expressing cells with the potent 
GC, triamcinolone acetonide (TA, 100 nM), for 48 h (Fig 2a), and then determined 
viability by Trypan blue exclusion.  MKP-1 overexpression did not significantly change 
cell viability after TA exposure.  In addition, lower concentrations of TA yielded similar 
results (data not shown).  To evaluate MKP-1 in the context of an additional 
chemotherapeutic, we also treated both cell lines with the DNA replication inhibitor 
hydroxyurea (HU, 3 mM). MKP-1 overexpression caused partial resistance to HU, 
consistent with the role of the MKP-1 substrates JNK and p38 in the cellular DNA 
damage response.  A derivative of the 697 line that stably expresses a dominant negative 
allele of caspase-9 (Planey et al. 2003), which was included as a positive control for drug 
resistance, retained viability after treatment with either drug.  In addition to determining 
viability by microscopy, we also performed cell cycle analysis by propidium iodide 
staining followed by flow cytometry.  Following a 48 h exposure to 100 nM TA, the 
majority of the cells contained <2n DNA content, indicating cell death. MKP-1 
overexpression did not reduce the percentage of sub-G0/G1 cells after TA treatment (and 
surprisingly slightly increased this value).  As expected for a compound that confers 
chemoresistance, MKP-1 overexpression decreased the accumulation of sub-G0/G1 cells 
after hydroxyurea treatment by 40%. Furthermore, we investigated the effect of 
exogenous MKP-1 expression on GC-induced activation of caspase-3, the primary 
effector caspase of the intrinsic apoptosis pathway (Fig. 2e).  A 16 h exposure to 100 nM 
TA induced cleavage of the fluorescent caspase-3 substrate peptide, DEVD-AFC, to the 
same extent in both cell lines.  Interestingly, a higher level of baseline caspase-3 activity 
was observed in the cells overexpressing MKP-1.  Taken together, these data demonstrate 
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that increasing MKP-1 levels does not significantly modulate GC sensitivity in an ALL 
cell culture model. 
In order to determine the effect of reducing the concentration of specific mRNAs 
on GC sensitivity, we optimized a method for electroporating small interfering RNAs 
(siRNAs) into 697 cells (Abrams et al. 2004).  48 h after electroporating a nonspecific 
Cy3-labeled siRNA, fluorescence was detected in nearly 100% of the cells (and was 
predominantly cytoplasmic as expected), although there was considerable heterogeneity 
in RNA uptake within the population (Fig 3a).  We then designed 3 RNA duplexes 
targeting different regions of MKP-1 mRNA (Fig 3b).  A BLAST search revealed no 
significant homology with other potential targets in the genome (data not shown).    To 
determine if these siRNAs specifically reduce MKP-1 protein levels, 1 µM of each 
duplex was separately electroporated into the cells overexpressing MKP-1.  A pool 
containing 0.33 µM of each in the same transfection mix was also tested in both the 
MKP-1 overexpressing cells and parental 697 cells.  48 h later, the cells were harvested 
and lysates were subjected to immunoblot analysis using an anti-MKP-1 antibody (Fig 
3c).  All three siRNAs, as well as the pool, reduced MKP-1 protein levels by more than 
50% as compared to a control siRNA sequence.  These lysates were also tested with an 
antibody against the housekeeping enzyme GAPDH as a loading control.  To determine 
the effect of MKP1 silencing on GC sensitivity, the MKP1 siRNA pool was transfected 
into wild type 697 cells for 48 h, followed by 48 h exposure to 5 nM TA.  This low 
concentration of TA, which is close to its Kd for binding to GR (Zhang and Danielsen 
1995), was selected so that small changes in sensitivity could be detected.  Cell viability 
was determined by flow cytometry after staining with the fluorescent DNA intercalator 7-
aminoactinomycin-D, which can only penetrate dead or dying cells (Lecoeur et al. 2002) 
(Fig 3d).  Viability data were also confirmed by Trypan blue exclusion (data not shown).  
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GC-induced cell death occurred in 9.6±1.9% more of the cells transfected with MKP1 
siRNA as compared to a control siRNA sequence that targets firefly luciferase.  These 
data demonstrate that considerable silencing of MKP-1 expression only modestly 
increases GC sensitivity. 
In order to achieve a greater level of MKP1 silencing, we used flow cytometry to 
isolate a population of cells enriched for a high level of siRNA internalization after 
transfection.  To accomplish this, we spiked the control or MKP1 siRNAs with a FITC-
labeled nonspecific siRNA at a ratio of 4:1.  As a proof-of-principle experiment for this 
enriching method, the labeled siRNA was transfected into the 697 cells that overexpress 
MKP-1, and cell sorting was performed based on FITC content 18 h later (Fig 4a).  Cells 
were allowed to recover for 24 h after sorting in normal growth medium at 37ºC, at which 
time they were harvested and immunoblotted.  Both populations containing the MKP1 
siRNA had reduced MKP-1 protein levels compared to the control siRNA, but we 
observed enriched silencing in the high FITC fraction (Fig. 4b).  After developing this 
protocol, we determined whether maximizing MKP1 silencing by sorting increased GC 
sensitivity.  Wild type 697 cells were sorted as above, and 5 nM TA was added after a 24 
h recovery.  After a 48 h drug exposure, viability was determined by 7-AAD staining as 
in Fig. 3d (Fig 4c).  When comparing the control siRNA to the MKP1 pool in each 
population (low FITC vs. high FITC), GC sensitivity increased only slightly in the cells 
enriched for siRNA internalization (Fig. 4d).  Collectively, these data demonstrate that 
using genetic methods to cause modulations in MKP-1 protein levels have a relatively 
minor impact on GC-induced cell death in pre-B ALL cells. 
 
DISCUSSION 
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 MKP-1 overexpression confers resistance to ultraviolet UV radiation, cisplatin, 
paclitaxel, doxorubicin, and Fas ligand in well characterized in vitro models (Franklin et 
al. 1998; Sanchez-Perez et al. 2000; Srikanth et al. 1999; Wu et al. 2004).  In this study, 
we also observed that MKP-1 overexpression renders 697 pre-B ALL cells resistant to 
hydroxyurea.  Furthermore, siRNA, antisense or small molecule inhibitors of MKP-1 all 
exhibited drug sensitizing or antiproliferative effects in tumor cells (Guo et al. 1998; Liao 
et al. 2003; Wu et al. 2004).  These data suggest that MKP-1 functions as a generalized 
resistance gene, affecting cell death induced by agents that initiate both intrinsic 
(caspase-9 mediated) apoptosis, such as DNA damage inducers, and extrinsic (caspase-8 
mediated) apoptosis, such as Fas ligand. In this study, we investigated the role of MKP-1 
in GC-induced apoptosis in pre-B ALL cells.  We observed that MKP-1 overexpression 
did not confer GC resistance and that MKP-1 knockdown only slightly increased GC 
sensitivity (9.6±1.9%).  These conclusions underscore the complexity and unique 
mechanism of glucocorticoid-induced apoptosis. 
 Inhibition of MKP-1 might contribute to therapy of solid tumors in the future.   
One recent study (Small et al. 2004) effectively demonstrated that antagonizing MKP-1 
by either siRNA or anthracyclines increases the extent of apoptosis induced by 
proteasome inhibitors in breast carcinoma cells.  In another, downregulation of MKP-1 
by antisense DNA decreased growth of pancreatic tumors in a nude mouse model (Liao et 
al. 2003).  Finally, in addition to its potential therapeutic value, MKP-1 expression may 
also have prognostic value, as it was shown to be a predictor of survival in non-small cell 
lung cancer.  Based on our study, however, we predict that MKP-1 inhibition will have 
limited utility in sensitizing leukemias and lymphomas to GCs. 
 There are numerous examples of other GR target genes that, when overexpressed, 
confer GC resistance in leukemic cells.  These include BCL2 (Planey et al. 2003), 
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catalase (Tome et al. 2003), and dig120 (Wang et al. 2003b).  In addition, we have 
recently reported that siRNA silencing of the pro-apoptotic BCL2 relative BIM, a target 
for GC-mediated repression, partially inhibits GC-induced apoptosis (Abrams et al. 
2004).  Therefore, the mechanism of GC-induced apoptosis is likely to involve the 
combinatorial effect of activation or repression of numerous specific genes by the GR.  
MKP-1 is likely to be a key mediator of GC-induced survival in breast cancer cells (Wu 
et al. 2004), but not GC-induced apoptosis in leukemia as previously hypothesized 
(Planey et al. 2003).   
 One of the most important unresolved issues in GC biology is that GR activation 
causes apoptosis in some tissues and survival in others.  These observations are directly 
related to the fact that the transcriptional program activated by GC is highly dependent on 
the cellular context.  MKP-1 can either be induced or repressed by GC depending on the 
tissue (see Introduction).   Another example of this phenomenon is that while Bcl-2 
protein and its proapoptotic family member Bim are oppositely regulated by GC in 697 
cells (Planey et al. 2003), CEM T-lymphocytes (Wang et al. 2003a) and S49A murine 
lymphoma cells (Wang et al. 2003a), neither appear to be affected in MCF-7 breast 
cancer cells (Wu et al. 2004) or U20S osteosarcoma cells (Rogatsky et al. 2003).  
Understanding the mechanism of tissue specificity of GR activation outcomes is critical 
to developing novel therapeutic strategies for GC resistant cancers. 
 
ACKNOWLEDGEMENTS 
 
The authors would like to thank Paul Hallberg for providing flow cytometry expertise, 
and Dr.’s Chris Franklin and Steve Keyes for providing MKP1 cDNA constructs. 
 
14
REFERENCES 
Abrams MT, Robertson NM, Yoon K, Wickstrom E (2004) Inhibition of glucocorticoid-
induced apoptosis by targeting the major splice variants of BIM with siRNA and 
shRNA. J Biol Chem  
Bang YJ, Kwon JH, Kang SH, Kim JW, Yang YC (1998) Increased MAPK activity and 
MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res 
Commun 250: 43-7 
Caplen NJ, Mousses S (2003) Short interfering RNA (siRNA)-mediated RNA 
interference (RNAi) in human cells. Ann N Y Acad Sci 1002: 56-62 
Clark AR (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of 
glucocorticoids? J Endocrinol 178: 5-12 
Cortes JE, Kantarjian HM (1995) Acute lymphoblastic leukemia. A comprehensive 
review with emphasis on biology and therapy. Cancer 76: 2393-417 
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes 
of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. 
Nature 411: 494-8 
Findley HW, Jr., Cooper MD, Kim TH, Alvarado C, Ragab AH (1982) Two new acute 
lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 60: 1305-9 
Franklin CC, Srikanth S, Kraft AS (1998) Conditional expression of mitogen-activated 
protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced 
apoptosis. Proc Natl Acad Sci U S A 95: 3014-9 
Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM (1996) Differential regulation 
of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity 
phosphatase. Embo J 15: 3621-32 
Guo YL, Kang B, Williamson JR (1998) Inhibition of the expression of mitogen-
activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis 
factor-alpha in rat mesangial cells. J Biol Chem 273: 10362-6 
Kamps MP, Look AT, Baltimore D (1991) The human t(1;19) translocation in pre-B 
ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing 
transforming potentials. Genes Dev 5: 358-68 
Kurt RA, Urba WJ, Smith JW, Schoof DD (1998) Peripheral T lymphocytes from women 
with breast cancer exhibit abnormal protein expression of several signaling 
molecules. Int J Cancer 78: 16-20 
Lecoeur H, de Oliveira-Pinto LM, Gougeon ML (2002) Multiparametric flow cytometric 
analysis of biochemical and functional events associated with apoptosis and 
oncosis using the 7-aminoactinomycin D assay. J Immunol Methods 265: 81-96 
Liao Q, Guo J, Kleeff J, Zimmermann A, Buchler MW, Korc M, Friess H (2003) Down-
regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity 
of pancreatic cancer cells. Gastroenterology 124: 1830-45 
McEwan IJ, Wright AP, Gustafsson JA (1997) Mechanism of gene expression by the 
glucocorticoid receptor: role of protein-protein interactions. Bioessays 19: 153-60 
McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C 
(1999) Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel 
WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A 
96: 11464-9 
Planey SL, Abrams MT, Robertson NM, Litwack G (2003) Role of apical caspases and 
glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B 
leukemic cells. Cancer Res 63: 172-8 
15
Planey SL, Derfoul A, Steplewski A, Robertson NM, Litwack G (2002) Inhibition of 
glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the 
mineralocorticoid receptor N-terminal domain. J Biol Chem 277: 42188-96 
Planey SL, Litwack G (2000) Glucocorticoid-induced apoptosis in lymphocytes. 
Biochem Biophys Res Commun 279: 307-12 
Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui CH, Crist WM, Look AT, 
Rivera GK (1990) Cytogenetics of pre-B-cell acute lymphoblastic leukemia with 
emphasis on prognostic implications of the t(1;19). J Clin Oncol 8: 1380-8 
Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont 
BD, Garabedian MJ, Yamamoto KR (2003) Target-specific utilization of 
transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad 
Sci U S A 100: 13845-50 
Rutherford MN, Bayly GR, Matthews BP, Okuda T, Dinjens WM, Kondoh H, LeBrun 
DP (2001) The leukemogenic transcription factor E2a-Pbx1 induces expression of 
the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 15: 
362-70 
Sanchez-Perez I, Martinez-Gomariz M, Williams D, Keyse SM, Perona R (2000) 
CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. 
Oncogene 19: 5142-52 
Slack DN, Seternes OM, Gabrielsen M, Keyse SM (2001) Distinct binding determinants 
for ERK2/p38alpha and JNK map kinases mediate catalytic activation and 
substrate selectivity of map kinase phosphatase-1. J Biol Chem 276: 16491-500 
Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ (2004) 
Evidence that Mitogen-activated Protein Kinase Phosphatase-1 Induction by 
Proteasome Inhibitors Plays an Anti-apoptotic Role. Mol Pharmacol  
Srikanth S, Franklin CC, Duke RC, Kraft RS (1999) Human DU145 prostate cancer cells 
overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to 
Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell 
Biochem 199: 169-78 
Tissing WJ, Meijerink JP, den Boer ML, Pieters R (2003) Molecular determinants of 
glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. 
Leukemia 17: 17-25 
Tome ME, Lutz NW, Briehl MM (2003) Overexpression of catalase or Bcl-2 delays or 
prevents alterations in phospholipid metabolism during glucocorticoid-induced 
apoptosis in WEHI7.2 cells. Biochim Biophys Acta 1642: 149-62 
Wang Z, Malone MH, He H, McColl KS, Distelhorst CW (2003a) Microarray analysis 
uncovers the induction of the proapoptotic BH3-only protein Bim in multiple 
models of glucocorticoid-induced apoptosis. J Biol Chem 278: 23861-7 
Wang Z, Malone MH, Thomenius MJ, Zhong F, Xu F, Distelhorst CW (2003b) 
Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced 
rapidly by diverse apoptotic signals. J Biol Chem 278: 27053-8 
Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD (2004) Microarray 
analysis reveals glucocorticoid-regulated survival genes that are associated with 
inhibition of apoptosis in breast epithelial cells. Cancer Res 64: 1757-64 
Zhang S, Danielsen M (1995) 8-Br-cAMP does not convert antagonists of the 
glucocorticoid receptor into agonists. Recent Prog Horm Res 50: 429-35 
 
16
 
FIGURE LEGENDS 
 
Figure 1. Overexpression of MKP-1 in 697 cells. A, Detection of MKP-1 protein in four 
stable, clonally-isolated cell lines derived from 697 after transfection of MKP-1/pcDNA3 
plasmid and selection in G418.  Vec, empty vector-transfected control cell line.  B, Real-
time RT-PCR detection of MKP-1 mRNA and 18S rRNA as a normalization control.  
Amplification plot shows accumulation of fluorescent PCR products as a function of PCR 
cycle.  The data corresponding to the empty vector control and the MKP-1 
overexpressing 697 cells (clone 4) are indicated.  Each cell line was tested in duplicate. 
 
Figure 2. Effect of MKP-1 overexpression on sensitivity to hydroxyurea and 
glucocorticoid.  A, 697/pcDNA3 (white bars); 697/pcDNA3-MKP1 (black bars); and 
697/pcDNA3-DNCasp9 (striped bars) were treated with 3 mM hydroxyurea (HU), 100 
nM triamcinolone acetonide (TA), or vehicle (0.1% ethanol) for 48 h.  Percent viability 
was determined by Trypan blue exclusion.  Error bars on HU and TA data represent the 
SEM (n=3). B, Cell lines were treated as above with HU, TA, or vehicle as indicated, 
fixed, stained with propidium iodide and subjected to cell cycle analysis by flow 
cytometry.  The stages of the cell cycle are indicated as follows: sub G0/G1 (black); G1 
(white); S(striped); G2/M (dotted).  Cell lines are abbreviated as Vec, 697/pCDNA3; 
MKP, 697/pcDNA3-MKP1; DN9, 697/pcDNA3-DNCasp9. E, Cell lines were treated as 
above in triplicate with TA (white bars) or vehicle (black bars) and assayed for caspase-3 
activity by cleavage of fluorescent DEVD peptide. Error bars represent SEM (n=3). 
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Figure 3. Validation of MKP-1 siRNA and effect on GC sensitivity.  A, 697 cells were 
transfected by electroporation with 1 µM Cy3-labeled siRNA and visualized 48 h later by 
fluorescence microscopy at 40x.  B, Open reading frame of MKP1 cDNA showing 
selected siRNA targets.  C, 1 µM of control or MKP1-specific siRNAs, or a pool of 0.33 
µM each of three MKP1 siRNAs, were transfected into 697/pcDNA3-MKP1 cells (top) or 
parental 697 cells (bottom).  After 48 h, whole-cell lysates were assayed by immunoblot 
with anti-MKP-1 and anti-GAPDH antibodies.  Ctrl, control siRNA sequence; lanes 
labeled 1-3 correspond to the target sequences shown in B. D, 697 cells were transfected 
with the control siRNA (white bars) or the MKP1 pool siRNA (black bars).  After 48 h, 
cells were treated with vehicle or 5 nM TA for 48 h, then assayed for viability by 7-AAD 
as described in Materials and Methods.  The error bars represent the SEM (n=3). 
 
Figure 4. Cell sorting increases siRNA silencing potency.  A, 697/pcDNA3-MKP1 cells 
were mock transfected (left) or transfected with the MKP1 siRNA pool spiked with 
FITC-labeled siRNA (right) as described.  Histograms show distribution of fluorescence 
in cell population, and “C” and “B” labels on the right histogram correspond to fractions 
collected for the low-FITC and high-FITC fractions (respectively) assayed in B. B, 24 h
after sorting, whole cell lysates were subject to immunoblot with indicated antibodies.  
Ctrl, control siRNA sequence. C, 697 cells were transfected and sorted as above.  24 h 
after sorting, the low-FITC and high-FITC populations were treated with vehicle or 5 nM 
TA for 48 h, and assayed for viability by 7-AAD as described in Materials and Methods. 
Control siRNA, white bars; MKP1 siRNA, black bars. 
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